Market Tracker

10/30 10:28am ET

NewLink Genetics Corp (NASDAQ:NLNK)

34.90
Data as of 10:12am ET
 +0.39 / +1.13%
Today’s Change
16.00
Today|||52-Week Range
53.48
+58.56%
Year-to-Date

Today’s Trading

Previous close34.51
Today’s open34.31
Day’s range33.50 - 35.47
Volume150,018
Average volume (3 months)985,901
Market cap$963.1M
Dividend yield--
Data as of 10:12am ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-23.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book15.72

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.01+0.11%
ARNAArena Pharmaceutical...+0.01+0.23%
EPZMEpizyme Inc+0.34+1.28%
TSROTESARO Inc+0.64+2.32%
Data as of 10:28am ET, 10/30/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts